Page last updated: 2024-09-03

imatinib mesylate and Subarachnoid Hemorrhage

imatinib mesylate has been researched along with Subarachnoid Hemorrhage in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimoto, M; Imanaka-Yoshida, K; Shiba, M; Suzuki, H; Taki, W; Yoshida, T1
Krafft, PR; Lekic, T; Ma, Q; Souvenir, R; Tang, J; Zhan, Y; Zhang, JH1
Fujimoto, M; Imanaka-Yoshida, K; Kanamaru, K; Kawakita, F; Shiba, M; Suzuki, H; Taki, W; Yoshida, T1
Changlong, Z; Guangwei, Z; Xiaochuan, S; Xiaohui, X; Xuenong, H; Yanfeng, X1
Fujimoto, M; Imanaka-Yoshida, K; Kanamaru, K; Matsushima, S; Shiba, M; Shimojo, N; Suzuki, H; Taki, W; Yoshida, T2

Other Studies

6 other study(ies) available for imatinib mesylate and Subarachnoid Hemorrhage

ArticleYear
Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats.
    Translational stroke research, 2014, Volume: 5, Issue:2

    Topics: Animals; Apoptosis; Benzamides; Disease Models, Animal; Imatinib Mesylate; Neurons; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Tenascin; Vasospasm, Intracranial

2014
Imatinib preserves blood-brain barrier integrity following experimental subarachnoid hemorrhage in rats.
    Journal of neuroscience research, 2015, Volume: 93, Issue:1

    Topics: Animals; Benzamides; Blood-Brain Barrier; Brain Edema; Capillary Permeability; Disease Models, Animal; Imatinib Mesylate; Immunoprecipitation; Male; MAP Kinase Kinase 4; Neurologic Examination; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins pp60(c-src); Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor alpha; Subarachnoid Hemorrhage

2015
Effects of tenascin-C on early brain injury after subarachnoid hemorrhage in rats.
    Acta neurochirurgica. Supplement, 2015, Volume: 120

    Topics: Animals; Benzamides; Brain Injuries; Disease Models, Animal; Imatinib Mesylate; In Situ Nick-End Labeling; Male; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Tenascin; Up-Regulation

2015
The Role of Platelet-Derived Growth Factor Receptor in Early Brain Injury Following Subarachnoid Hemorrhage.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2016, Volume: 25, Issue:9

    Topics: Animals; Anthracenes; Antineoplastic Agents; Brain Edema; Brain Injuries; Caspase 3; Disease Models, Animal; Double-Blind Method; Enzyme Inhibitors; Gene Expression Regulation; Hippocampus; Imatinib Mesylate; In Situ Nick-End Labeling; Male; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Subarachnoid Hemorrhage

2016
Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats.
    Neurobiology of disease, 2012, Volume: 46, Issue:1

    Topics: Animals; Benzamides; Disease Models, Animal; Imatinib Mesylate; Male; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Tenascin; Vasospasm, Intracranial

2012
Role of platelet-derived growth factor in cerebral vasospasm after subarachnoid hemorrhage in rats.
    Acta neurochirurgica. Supplement, 2013, Volume: 115

    Topics: Animals; Benzamides; Carbon; Carotid Artery, Internal; Coronary Angiography; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Gene Expression Regulation; Imatinib Mesylate; Male; Neurologic Examination; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Subarachnoid Hemorrhage; Vasospasm, Intracranial

2013